Paclitaxel is an antineoplastic agent indicated for the treatment of different types of cancer including ovarian cancer, breast cancer, advanced non-small cell lung cancer (NSCLC) and AIDS-related Kaposi's sarcoma (KS). Paclitaxel might be use alone or in combination with other drugs such as anthracycline or trastuzumab depending on the therapeutic application and previous response of the patient to other therapies. It is presented in glass vial containing a 6mg/mL concentrate for solution for infusion in four different strengths 30mg, 100mg, 300mg and 600mg. Each vial is packaged separately in a box. Also available a package of 10 boxes.